193 related articles for article (PubMed ID: 33335699)
1. Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting.
Moradi O; Karimzadeh I; Davani-Davari D; Shafiekhani M; Sagheb MM; Raees-Jalali GA
Int J Organ Transplant Med; 2020; 11(4):185-195. PubMed ID: 33335699
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.
Zhang J; Ma D; Chen M; Hu Y; Chen X; Chen J; Huang M; Dai H
Front Pharmacol; 2024; 15():1308260. PubMed ID: 38379901
[No Abstract] [Full Text] [Related]
3. Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran.
Moradi O; Karimzadeh I; Davani-Davari D; Shafiekhani M; Sagheb MM
Patient Prefer Adherence; 2019; 13():729-738. PubMed ID: 31190755
[No Abstract] [Full Text] [Related]
4. Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Gago-Sánchez AI; Font P; Cárdenas M; Aumente MD; Del Prado JR; Calleja MÁ
Pharmacol Res Perspect; 2021 Dec; 9(6):e00892. PubMed ID: 34755493
[TBL] [Abstract][Full Text] [Related]
5. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
[TBL] [Abstract][Full Text] [Related]
6. Impact of Clinical Pharmacist's Interventions on Potential Drug-Drug Interactions in the Cardiac Care Units of Two University Hospitals in Shiraz, South of Iran.
Shafiekhani M; Moosavi N; Firouzabadi D; Namazi S
J Res Pharm Pract; 2019; 8(3):143-148. PubMed ID: 31728345
[TBL] [Abstract][Full Text] [Related]
7. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
8. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay.
Sanchez L; Bacle A; Lamy T; Le Corre P
Cancer Chemother Pharmacol; 2019 May; 83(5):827-835. PubMed ID: 30758649
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of drug-drug interactions in cancer therapy and the clinical outcomes.
Alnaim LS; Almalki HM; Almutairi AM; Salamah HJ
Life Sci; 2022 Dec; 310():121071. PubMed ID: 36243121
[TBL] [Abstract][Full Text] [Related]
15. Potentially inappropriate medications involved in drug-drug interactions at hospital discharge in Croatia.
Marinović I; Bačić Vrca V; Samardžić I; Marušić S; Grgurević I
Int J Clin Pharm; 2021 Jun; 43(3):566-576. PubMed ID: 33001315
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
17. High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.
Busari AA; Oreagba IA; Oshikoya KA; Kayode MO; Olayemi SO
Niger Med J; 2019; 60(6):317-325. PubMed ID: 32180663
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study.
Zhao M; Liu CF; Feng YF; Chen H
Front Pharmacol; 2022; 13():946415. PubMed ID: 36091832
[No Abstract] [Full Text] [Related]
19. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
Kuypers DR
Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
[TBL] [Abstract][Full Text] [Related]
20. Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.
Marusic S; Bacic-Vrca V; Obreli Neto PR; Franic M; Erdeljic V; Gojo-Tomic N
Eur J Clin Pharmacol; 2013 Sep; 69(9):1717-24. PubMed ID: 23739998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
